The majority had serous adenocarcinoma (n = 90 of 109 ... The most common sites for lesions found by NIR alone were pelvic (36%), sigmoid/rectosigmoid epiploica (26%), paracolic gutter (13%), and ...

OS was defined as the time between the dates of diagnosis of the adenocarcinoma and death due to any cause or due to last follow-up for patients alive. Additionally, OS starting from the date of OM ...

From the Medical and Psychiatric Clinics of the Massachusetts General Hospital and the Departments of Medicine and Diseases of the Nervous System of the Harvard Medical School. * Jeffrey ...

From the Anaphylactic Clinic and the Medical Research Department, Beth Israel Hospital, Boston, and the Department of Medicine, Harvard Medical School. * Teaching fellow in medicine, Harvard ...

qDepartment of Hepatogastroenterology and Digestive Oncology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France rDepartment of Gastroenterology and Digestive Oncology, ...

Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, especially the most malignant proximal-proliferative subtype without ...

Patients with ulcerative colitis (UC) are at increased risk of colorectal carcinoma. 1, 2 Many clinicians practice colonoscopic surveillance in these patients in the hope of detecting dysplasia or an ...

Methods: A Markov model with three health states was developed to assess the cost-effectiveness of CAD-CHM in HER2-negative advanced G/GEJ adenocarcinoma. Clinical efficacy data were sourced from the ...

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

1 Department of Gastroenterology and Hepatology, General Hospital Idrrisa Pouye, Dakar, Senegal. 2 Department of Gastroenterology and Hepatology, Aristide Le Dantec Hospital, Dakar, Senegal. Digestive ...